FIELD: medicine.
SUBSTANCE: invention relates to salicyluric acid derivative of formula , given below, which possesses cerebroprotective activity.
EFFECT: compound can be applied in chemical-pharmaceutical field to obtain effective cerebroprotective medications.
4 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
4-[(4-ACETOXYBENZOYL)AMINO]BUTYRATE OF LITHIUM, HAVING CEREBROPROTECTIVE ACTION | 2015 |
|
RU2617233C2 |
POTASSIUM N-(4-ACETOXYBENZOYL)GLYCINATE POSSESSING CEREBROPROTECTIVE ACTIVITY | 2014 |
|
RU2556637C1 |
BASIC MAGNESIUM SALT OF N-(4-ACETOXYBENZOYL)GLYCINE HAVING CEREBROPROTECTIVE ACTION | 2014 |
|
RU2570204C1 |
DISODIUM SALT OF 3-HYDROXYHIPPURIC ACID, HAVING ANTIHYPOXIC AND CEREBROPROTECTIVE ACTION | 2014 |
|
RU2559875C1 |
N-(ACETYLSALICYLOYL)PYRAZOL WITH CEREBROPROTECTOR ACTION IN CASE OF CEREBRAL CIRCULATION INSUFFICIENCY | 2016 |
|
RU2632005C1 |
AGENT POSSESSING NEUROPROTECTIVE ACTION IN ISCHEMIC CEREBRAL CIRCULATION DISORDER | 2015 |
|
RU2586301C1 |
AGENT POSSESSING CEREBRAL-PROTECTIVE, ENDOTHELIAL-POSITIVE AND ANTITHROMBOTIC EFFECT | 2015 |
|
RU2594254C1 |
4-(4-ACETOXYBENZOYLAMINO)BUTANOYLGLYCINE, WHICH HAS A CEREBROPROTECTIVE ACTION IN CEREBRAL ISCHEMIA | 2017 |
|
RU2657820C1 |
NEW WATER-SOLUBLE SALICYLAMIDE DERIVATIVE WITH NEUROPROTECTIVE ACTION IN CASE OF CEREBRAL CIRCULATION INSUFFICIENCY | 2017 |
|
RU2641102C1 |
AGENT ELICITING ANTI-ISCHEMIC, HYPOTENSIVE, ANTI- -ARRHYTHMIC AND NOOTROPIC ACTIVITY | 2002 |
|
RU2216322C1 |
Authors
Dates
2015-12-10—Published
2014-07-23—Filed